AlloMap is the only non-invasive gene expression test that helps physicians identify the absence* of heart transplant rejection
- Provides Actionable Information: Quantifiable, objective, and reproducible test results
- Offers Patient Comfort: Only requires a simple blood draw
- Widely Adopted: Successfully used in over 21,000 cases to help physicians detect the absence* of heart transplant rejection at the time of testing in 7,000+ heart transplant patients
*Absence is defined here as the very low probability of moderate/severe acute cellular rejection as measured by the negative predictive value. AlloMap test results are only to be used in conjunction with standard clinical assessment.